Neurofilament Light Chain: Blood Biomarker of Neonatal Neuronal Injury

Background: Neurofilament light chain (NfL) is a highly promising biomarker of neuroaxonal injury that has mainly been studied in adult neurodegenerative disease. Its involvement in neonatal disease remains largely unknown. Our aim was to establish NfL plasma concentrations in preterm and term infan...

Full description

Bibliographic Details
Main Authors: Antoinette Depoorter, Roland P. Neumann, Christian Barro, Urs Fisch, Peter Weber, Jens Kuhle, Sven Wellmann
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-11-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2018.00984/full
id doaj-5c1ee6eb17904e00958c1e7c94846562
record_format Article
spelling doaj-5c1ee6eb17904e00958c1e7c948465622020-11-24T21:46:37ZengFrontiers Media S.A.Frontiers in Neurology1664-22952018-11-01910.3389/fneur.2018.00984411107Neurofilament Light Chain: Blood Biomarker of Neonatal Neuronal InjuryAntoinette Depoorter0Roland P. Neumann1Christian Barro2Urs Fisch3Peter Weber4Jens Kuhle5Sven Wellmann6Department of Neuropediatrics and Developmental Medicine, University Children's Hospital Basel, University of Basel, Basel, SwitzerlandDepartment of Neonatology, University Children's Hospital Basel, University of Basel, Basel, SwitzerlandNeurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, SwitzerlandNeurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, SwitzerlandDepartment of Neuropediatrics and Developmental Medicine, University Children's Hospital Basel, University of Basel, Basel, SwitzerlandNeurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, SwitzerlandDepartment of Neonatology, University Children's Hospital Basel, University of Basel, Basel, SwitzerlandBackground: Neurofilament light chain (NfL) is a highly promising biomarker of neuroaxonal injury that has mainly been studied in adult neurodegenerative disease. Its involvement in neonatal disease remains largely unknown. Our aim was to establish NfL plasma concentrations in preterm and term infants in the first week of life.Methods: Plasma NfL was measured by single molecule array immunoassay in two neonatal cohorts: cohort 1 contained 203 term and preterm infants, median gestational age (GA) 37.9 weeks (interquartile range [IQR] 31.9–39.4), in whom venous and arterial umbilical cord blood was sampled at birth and venous blood at day of life (DOL) 3; cohort 2 contained 98 preterm infants, median GA 29.3 weeks (IQR 26.9–30.6), in whom venous blood was sampled at DOL 7.Results: Median NfL concentrations in venous blood increased significantly from birth (18.2 pg/mL [IQR 12.8–30.8, cohort 1]) to DOL 3 (50.9 pg/mL [41.3–100, cohort 1]) and DOL 7 (126 pg/mL [78.8–225, cohort 2]) (p < 0.001). In both cohorts NfL correlated inversely with birth weight (BW, Spearman's rho −0.403, p < 0.001, cohort 1; R −0.525, p < 0.001, cohort 2) and GA (R −0.271, p < 0.001, cohort 1; R −0.487, p < 0.001, cohort 2). Additional significant correlations were found for maternal age at delivery, preeclampsia, delivery mode, 5-min Apgar, duration of oxygen supplementation, sepsis, and brain damage (intraventricular hemorrhage or periventricular leukomalacia). Multivariable logistic regression analysis identified the independent predictors of NfL in cohort 1 as BW (beta = −0.297, p = 0.003), delivery mode (beta = 0.237, p = 0.001) and preeclampsia (beta = 0.183, p = 0.022) and in cohort 2 as BW (beta = −0.385, p = 0.001) and brain damage (beta = 0.222, p = 0.015).Conclusion: Neonatal NfL levels correlate inversely with maturity and BW, increase during the first days of life, and relate to brain injury factors such as intraventricular hemorrhage and periventricular leukomalacia, and also to vaginal delivery.https://www.frontiersin.org/article/10.3389/fneur.2018.00984/fullcerebral injuryneuropathologybiomarkerinfantparturitionprematurity
collection DOAJ
language English
format Article
sources DOAJ
author Antoinette Depoorter
Roland P. Neumann
Christian Barro
Urs Fisch
Peter Weber
Jens Kuhle
Sven Wellmann
spellingShingle Antoinette Depoorter
Roland P. Neumann
Christian Barro
Urs Fisch
Peter Weber
Jens Kuhle
Sven Wellmann
Neurofilament Light Chain: Blood Biomarker of Neonatal Neuronal Injury
Frontiers in Neurology
cerebral injury
neuropathology
biomarker
infant
parturition
prematurity
author_facet Antoinette Depoorter
Roland P. Neumann
Christian Barro
Urs Fisch
Peter Weber
Jens Kuhle
Sven Wellmann
author_sort Antoinette Depoorter
title Neurofilament Light Chain: Blood Biomarker of Neonatal Neuronal Injury
title_short Neurofilament Light Chain: Blood Biomarker of Neonatal Neuronal Injury
title_full Neurofilament Light Chain: Blood Biomarker of Neonatal Neuronal Injury
title_fullStr Neurofilament Light Chain: Blood Biomarker of Neonatal Neuronal Injury
title_full_unstemmed Neurofilament Light Chain: Blood Biomarker of Neonatal Neuronal Injury
title_sort neurofilament light chain: blood biomarker of neonatal neuronal injury
publisher Frontiers Media S.A.
series Frontiers in Neurology
issn 1664-2295
publishDate 2018-11-01
description Background: Neurofilament light chain (NfL) is a highly promising biomarker of neuroaxonal injury that has mainly been studied in adult neurodegenerative disease. Its involvement in neonatal disease remains largely unknown. Our aim was to establish NfL plasma concentrations in preterm and term infants in the first week of life.Methods: Plasma NfL was measured by single molecule array immunoassay in two neonatal cohorts: cohort 1 contained 203 term and preterm infants, median gestational age (GA) 37.9 weeks (interquartile range [IQR] 31.9–39.4), in whom venous and arterial umbilical cord blood was sampled at birth and venous blood at day of life (DOL) 3; cohort 2 contained 98 preterm infants, median GA 29.3 weeks (IQR 26.9–30.6), in whom venous blood was sampled at DOL 7.Results: Median NfL concentrations in venous blood increased significantly from birth (18.2 pg/mL [IQR 12.8–30.8, cohort 1]) to DOL 3 (50.9 pg/mL [41.3–100, cohort 1]) and DOL 7 (126 pg/mL [78.8–225, cohort 2]) (p < 0.001). In both cohorts NfL correlated inversely with birth weight (BW, Spearman's rho −0.403, p < 0.001, cohort 1; R −0.525, p < 0.001, cohort 2) and GA (R −0.271, p < 0.001, cohort 1; R −0.487, p < 0.001, cohort 2). Additional significant correlations were found for maternal age at delivery, preeclampsia, delivery mode, 5-min Apgar, duration of oxygen supplementation, sepsis, and brain damage (intraventricular hemorrhage or periventricular leukomalacia). Multivariable logistic regression analysis identified the independent predictors of NfL in cohort 1 as BW (beta = −0.297, p = 0.003), delivery mode (beta = 0.237, p = 0.001) and preeclampsia (beta = 0.183, p = 0.022) and in cohort 2 as BW (beta = −0.385, p = 0.001) and brain damage (beta = 0.222, p = 0.015).Conclusion: Neonatal NfL levels correlate inversely with maturity and BW, increase during the first days of life, and relate to brain injury factors such as intraventricular hemorrhage and periventricular leukomalacia, and also to vaginal delivery.
topic cerebral injury
neuropathology
biomarker
infant
parturition
prematurity
url https://www.frontiersin.org/article/10.3389/fneur.2018.00984/full
work_keys_str_mv AT antoinettedepoorter neurofilamentlightchainbloodbiomarkerofneonatalneuronalinjury
AT rolandpneumann neurofilamentlightchainbloodbiomarkerofneonatalneuronalinjury
AT christianbarro neurofilamentlightchainbloodbiomarkerofneonatalneuronalinjury
AT ursfisch neurofilamentlightchainbloodbiomarkerofneonatalneuronalinjury
AT peterweber neurofilamentlightchainbloodbiomarkerofneonatalneuronalinjury
AT jenskuhle neurofilamentlightchainbloodbiomarkerofneonatalneuronalinjury
AT svenwellmann neurofilamentlightchainbloodbiomarkerofneonatalneuronalinjury
_version_ 1725901079742251008